Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation

Ye Wang, Feng Xie, Ming Chai Kong, Lai Heng Lee, Heng Joo Ng, Yu Ko

Research output: Contribution to journalArticlepeer-review

25 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science